News

Americans are likely to face shortages and rising prices while we want for production to move to the U.S., Geoffrey Joyce ...
ST Xinchao announced that it was placed under investigation by the China Securities Regulatory Commission for failing to disclose its periodic report (2024 annual report) within the specified time ...
GLP-1 weight loss drugs cause a slew of skin issues, including laxity, discoloration and pronounced fine lines. Now, doctors, ...
WEC Energy Group has kicked off the year with a solid performance, as evident from their first-quarter 2025 earnings of $2.27 ...
Following the sell-off, Lilly trades at a forward price-to-earnings (P/E) of 37 times 2025 analyst estimates, with a price-to ...
The deal builds on an existing research collaboration between Eli Lilly and Alchemab to discover new ALS drugs.
Eli Lilly officials and Gov. Mike Braun break ground on the LEAP District's Lilly Medicine Foundry, a $4.5 billion project ...
Officials from the Indianapolis-based drugmaker said the Lilly Medicine Foundry will help streamline the process of ...
A former Boone County bean field is where Lilly will research, develop, and manufacture the medicines of the future. Company ...
Eli Lilly and Co. will break ground on its $4.5 billion Lilly Medicine Foundry in Lebanon, Indiana's LEAP Research and ...
Alchemab Therapeutics, a next-gen biopharmaceutical company, has entered into a licensing agreement with Eli Lilly and ...
Research and development (R&D) investment in the Swiss biotech sector grew in 2024, despite ongoing global funding struggles.